An interesting possibility would be that some (epi)-genetic events leading to MYC or AKT activity or inhibition of p53 activity and/or intrinsic apoptosis in PTCL cells would be substituted for by receptor/ligand interactions taking place in the tumor microenvironment in vivo. The gene discussed is MYC; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.